Academic Journal
Efficacy of Technology-Based Cognitive Rehabilitation Tools for Cancer-Related Cognitive Impairment in Non-CNS Cancer Patients: A Systematic Review.
| Τίτλος: | Efficacy of Technology-Based Cognitive Rehabilitation Tools for Cancer-Related Cognitive Impairment in Non-CNS Cancer Patients: A Systematic Review. |
|---|---|
| Συγγραφείς: | Capetti B; Applied Research Division for Cognitive and Psychological Science, European Institute of Oncology IRCCS, 20141 Milan, Italy.; Department of Oncology and Haemato-Oncology, University of Milan, 20122 Milan, Italy., Sdinami S; Applied Research Division for Cognitive and Psychological Science, European Institute of Oncology IRCCS, 20141 Milan, Italy., Luisi J; Applied Research Division for Cognitive and Psychological Science, European Institute of Oncology IRCCS, 20141 Milan, Italy., Conti L; Applied Research Division for Cognitive and Psychological Science, European Institute of Oncology IRCCS, 20141 Milan, Italy., Grasso R; Applied Research Division for Cognitive and Psychological Science, European Institute of Oncology IRCCS, 20141 Milan, Italy.; Department of Oncology and Haemato-Oncology, University of Milan, 20122 Milan, Italy., Pravettoni G; Applied Research Division for Cognitive and Psychological Science, European Institute of Oncology IRCCS, 20141 Milan, Italy.; Department of Oncology and Haemato-Oncology, University of Milan, 20122 Milan, Italy. |
| Πηγή: | Healthcare (Basel, Switzerland) [Healthcare (Basel)] 2026 Jan 18; Vol. 14 (2). Date of Electronic Publication: 2026 Jan 18. |
| Τύπος έκδοσης: | Journal Article; Review |
| Γλώσσα: | English |
| Στοιχεία περιοδικού: | Publisher: MDPI AG Country of Publication: Switzerland NLM ID: 101666525 Publication Model: Electronic Cited Medium: Print ISSN: 2227-9032 (Print) Linking ISSN: 22279032 NLM ISO Abbreviation: Healthcare (Basel) Subsets: PubMed not MEDLINE |
| Imprint Name(s): | Original Publication: Basel, Switzerland : MDPI AG, [2013]- |
| Περίληψη: | Background: Cancer-related cognitive impairment (CRCI) is a significant concern for individuals with non-central nervous system (non-CNS) cancers, affecting memory, attention, executive functions, and processing speed. Non-pharmacological interventions, including digital cognitive rehabilitation, have shown promise in addressing CRCI. This systematic review investigates the efficacy of digital and computerized cognitive rehabilitation interventions in improving cognitive outcomes in non-CNS cancer patients. Method: A systematic search of the EMBASE, Scopus, and PubMed databases was conducted to identify studies on digital and computerized cognitive rehabilitation for non-CNS cancer patients. Studies were included if they involved computerized and digital cognitive rehabilitation for oncological patients and assessed the efficacy of the intervention. A total of 11 studies were selected, including randomized controlled trials and quasi-experimental designs. The quality of the studies was assessed using the Mixed Methods Appraisal Tool (MMAT). Data was synthesized using a narrative descriptive approach, and the results were summarized in a descriptive table. Results: The most frequently assessed cognitive domains included working memory, attention, executive functions, and processing speed. The majority of studies (n = 11) demonstrated significant immediate improvements in cognitive functions, particularly in working memory, executive functions, attention, and processing speed. Short-term follow-up (1-5 months) showed partial maintenance of these improvements, while long-term effects (6 months to 1 year) were more variable. Improvements in episodic memory were less consistent, particularly among breast cancer survivors. Discussion: Digital and computerized cognitive rehabilitation appears to be an effective intervention for CRCI, providing immediate cognitive benefits and some lasting improvements, especially in domains such as memory and attention. However, long-term effects remain variable, and further research is needed to explore the optimal duration of interventions and the potential advantages of personalized rehabilitation approaches. |
| References: | Ann Oncol. 2019 Dec 1;30(12):1925-1940. (PMID: 31617564) BMJ. 2021 Mar 29;372:n71. (PMID: 33782057) J Clin Oncol. 2012 Oct 20;30(30):3675-86. (PMID: 23008308) Transl Psychiatry. 2024 Oct 23;14(1):447. (PMID: 39443463) Ann Palliat Med. 2024 Sep;13(5):1265-1280. (PMID: 39260437) J Clin Med. 2023 Nov 07;12(22):. (PMID: 38002583) Breast Cancer Res Treat. 2012 Oct;135(3):799-809. (PMID: 22918524) Psychooncology. 2025 May;34(5):e70182. (PMID: 40354124) Support Care Cancer. 2023 Feb 7;31(3):152. (PMID: 36746805) Front Oncol. 2024 Apr 23;14:1387251. (PMID: 38715789) J Clin Med. 2024 Mar 27;13(7):. (PMID: 38610702) Emerg Med J. 2020 Jun;37(6):387. (PMID: 32253195) Neurol Sci. 2019 Sep;40(9):1759-1774. (PMID: 31049790) Crit Rev Oncol Hematol. 2022 Dec;180:103859. (PMID: 36257539) Int J Environ Res Public Health. 2023 Mar 11;20(6):. (PMID: 36981862) Clin Breast Cancer. 2013 Aug;13(4):299-306. (PMID: 23647804) Int J Nurs Stud. 2020 Apr;104:103514. (PMID: 32004776) Future Oncol. 2024 Dec;20(40):3569-3578. (PMID: 39530545) Eur J Intern Med. 2014 Oct;25(8):685-8. (PMID: 25060407) Arch Phys Med Rehabil. 2000 Dec;81(12):1596-615. (PMID: 11128897) J Clin Oncol. 2017 Jan 10;35(2):217-225. (PMID: 28056205) Cancer. 2004 Jun 1;100(11):2292-9. (PMID: 15160331) Front Hum Neurosci. 2014 Jun 27;8:385. (PMID: 25018719) Health Psychol Rev. 2025 Jul 30;:1-65. (PMID: 40737021) JMIR Rehabil Assist Technol. 2018 Dec 06;5(2):e10714. (PMID: 30522994) Appl Neuropsychol Adult. 2025 Nov-Dec;32(6):1803-1818. (PMID: 38261545) Psychooncology. 2023 Dec;32(12):1848-1857. (PMID: 37882108) Digit Health. 2025 Jul 15;11:20552076251358297. (PMID: 40677519) Cancers (Basel). 2022 Sep 29;14(19):. (PMID: 36230678) J Clin Epidemiol. 2009 Oct;62(10):e1-34. (PMID: 19631507) JCO Oncol Pract. 2025 Oct;21(10):1377-1381. (PMID: 40043223) Front Neurol. 2024 Feb 15;15:1338873. (PMID: 38426164) Cancer. 2020 Dec 15;126(24):5328-5336. (PMID: 32996583) Pilot Feasibility Stud. 2018 Feb 17;4:50. (PMID: 29468085) Front Neurol. 2025 Jun 13;16:1608645. (PMID: 40584523) NPJ Breast Cancer. 2024 Sep 30;10(1):85. (PMID: 39349493) Front Neurol. 2025 Oct 07;16:1651443. (PMID: 41127285) CA Cancer J Clin. 2015 Mar;65(2):123-38. (PMID: 25483452) Neuropsychology. 2017 May;31(4):467-473. (PMID: 28150964) Digit Health. 2023 Aug 13;9:20552076231192754. (PMID: 37588161) Front Med (Lausanne). 2023 Jan 26;10:1132287. (PMID: 36778735) |
| Contributed Indexing: | Keywords: cancer-related cognitive impairment; cognitive rehabilitation; computerized cognitive rehabilitation; digital cognitive tools; efficacy; non-CNS cancer |
| Entry Date(s): | Date Created: 20260128 Date Completed: 20260128 Latest Revision: 20260131 |
| Update Code: | 20260131 |
| PubMed Central ID: | PMC12840888 |
| DOI: | 10.3390/healthcare14020239 |
| PMID: | 41595375 |
| Βάση Δεδομένων: | MEDLINE |
καταχωρήστε σχόλιο πρώτοι!